Skip to Main Content

NISH (NITAG Support Hub) 2: Covid-19 vaccine hesitancy/confidence in Africa: Sierra Leone (English)

This Library Guide contains published and unpublished information on vaccine hesitancy and related issues in the context of COVID-19 vaccination in Subsaharan Africa

PubMed Covid-19 AND vaccine hesitancy AND Sierra Leone

Lees, S., Enria, L. and James, M., 2023. Contesting the crisis narrative: epidemic accounts in Sierra Leone, Tanzania, and Democratic Republic of the Congo. Disasters.

 https://doi.org/10.1111/disa.12535

Yendewa, S.A., Ghazzawi, M., James, P.B., Smith, M., Massaquoi, S.P., Babawo, L.S., Deen, G.F., Russell, J.B., Samai, M., Sahr, F. and Lakoh, S., 2022. COVID-19 Vaccine Hesitancy among Healthcare Workers and Trainees in Freetown, Sierra Leone: A Cross-Sectional Study. Vaccines, 10(5), p.757.
https://pubmed.ncbi.nlm.nih.gov/35632513/
 
Faye, S.L.B., Krumkamp, R., Doumbia, S., Tounkara, M., Strauss, R., Ouedraogo, H.G., Sagna, T., Mbawah, A.K., Doumbia, C.O., Diouf, S. and Cisse, K., 2022. Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: a cross-sectional study. BMJ open, 12(4), p.e059138.
https://pubmed.ncbi.nlm.nih.gov/35418436/
 
Mobarak, A.M., Miguel, E., Abaluck, J., Ahuja, A., Alsan, M., Banerjee, A., Breza, E., Chandrasekhar, A.G., Duflo, E., Dzansi, J. and Garrett, D., 2022. End COVID-19 in low-and middle-income countries. Science, 375(6585), pp.1105-1110. (Not OA)
 
Leach, M., MacGregor, H., Akello, G., Babawo, L., Baluku, M., Desclaux, A., Grant, C., Kamara, F., Nyakoi, M., Parker, M. and Richards, P., 2022. Vaccine anxieties, vaccine preparedness: Perspectives from Africa in a Covid-19 era. Social science & medicine, 298, p.114826.
https://www.sciencedirect.com/science/article/pii/S0277953622001320
 
Solís Arce, J.S., Warren, S.S., Meriggi, N.F., Scacco, A., McMurry, N., Voors, M., Syunyaev, G., Malik, A.A., Aboutajdine, S., Adeojo, O. and Anigo, D., 2021. COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries. Nature medicine, 27(8), pp.1385-1394.
https://pubmed.ncbi.nlm.nih.gov/34272499/

Google Scholar

Sallam, M., Al-Sanafi, M. and Sallam, M., 2022. A global map of COVID-19 vaccine acceptance rates per country: an updated concise narrative review. Journal of Multidisciplinary Healthcare, 15, p.21.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760993/

Google Scholar

Peters, M.D., 2022. Addressing vaccine hesitancy and resistance for COVID-19 vaccines. International Journal of Nursing Studies, p.104241. (Not OA
Machingaidze, S. and Wiysonge, C.S., 2021. Understanding COVID-19 vaccine hesitancy. Nature Medicine, 27(8), pp.1338-1339. (Not OA)

SciVal Collaborators with Sierra Leone

Africa-Wide Information

Mobarak, A.M., Miguel, E., Abaluck, J., Ahuja, A., Alsan, M., Banerjee, A., Breza, E., Chandrasekhar, A.G., Duflo, E., Dzansi, J. and Garrett, D., 2022. End COVID-19 in low-and middle-income countries. Science, 375(6585), pp.1105-1110.(Not OA)
Abstract : Vaccines are changing the course of the COVID-19 pandemic, but in grossly uneven ways. Low- and middle-income countries (LMICs) face considerable obstacles in both receiving and distributing doses. To limit virus transmission, its devastating impacts, and opportunities for further mutations, this must change. Until it does, nonpharmaceutical interventions such as masking must remain a priority. Science invited global experts to highlight research and innovations aimed at quickening the end of COVID-19 in LMICs. —Brad Wible

Cochrane Library